Thursday, January 28, 2016 9:31:10 AM
Speaking from experience I can accurately state the following. With having multiple business interests, I must admit that you cannot give your full attention to each of them. You will never compete in an industry against a management that is all in and full time if your management is part time and distracted by other positions held. That being said, I find that Jim starting a wine company along with having other LLCs and being the CEO of a non revenue generating company, it makes total sense. Why bother focusing on AMIC when you have other things to do? Especially when you will get paid and collect a bonus anyway.
Real investors will never invest in a CEO that has more than 1 or possibly two corps going at once. Case in point, often said in -Shark Tank- "I want you working full time if I give you my money" and it is true. It is rare that you get a great team around you that can afford someone to do this. Seeing as how Jim has not turned a profit in any of his public businesses, you have to start to think does he actually want to or is this another way to fund one of his "other" companies. As an investor you really should ask yourself that. Jim is def not an Elon Musk or Jack Dorsey, the guy cannot even generate revenue let alone an actual profit
This is in correspondence to the CEO of ADMD not being able to generate revenues, scale ADMD, obtain even a distribution relationship to potentially generate revs, or even come close to making a profit. The company is still in massive debt and has a negative monthly / quarterly financial trajectory. To state otherwise is foolish due to the SEC financials proving this.
Real investors will never invest in a CEO that has more than 1 or possibly two corps going at once. Case in point, often said in -Shark Tank- "I want you working full time if I give you my money" and it is true. It is rare that you get a great team around you that can afford someone to do this. Seeing as how Jim has not turned a profit in any of his public businesses, you have to start to think does he actually want to or is this another way to fund one of his "other" companies. As an investor you really should ask yourself that. Jim is def not an Elon Musk or Jack Dorsey, the guy cannot even generate revenue let alone an actual profit
This is in correspondence to the CEO of ADMD not being able to generate revenues, scale ADMD, obtain even a distribution relationship to potentially generate revs, or even come close to making a profit. The company is still in massive debt and has a negative monthly / quarterly financial trajectory. To state otherwise is foolish due to the SEC financials proving this.
Recent RDGL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:45:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
